Advertisement

Topics

Embera NeuroTherapeutics, Inc. Company Profile

02:58 EDT 21st June 2018 | BioPortfolio

Embera NeuroTherapeutics, Inc. is a development stage pharmaceutical company focused on treating a broad range of addictions and obesity where the major clinical challenge is a limited range of effective drug therapies. Embera is developing a novel drug combination (EMB-001) targeting specific brain functions that drive craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder, Dr. Nicholas Goeders. Embera is advancing EMB-001 development programs in smoking cessation and cocaine dependence based on these results.


News Articles [7 Associated News Articles listed on BioPortfolio]

Biscayne Neurotherapeutics out-licenses Chinese rights to its novel antiepileptic

Clinical-stage US drug developer Biscayne Neurotherapeutics has signed a licensing agreement with Global…

AMRI Renews NIH Contract

Re-ups 10-year NIH contract to support the Blueprint Neurotherapeutics Network

AMRI renews 10-year $39.5m drug discovery contract

AMRI will provide various services supporting drug discovery programs in neurotherapeutics as part of a 10-year contract worth up to $39.5m.

Genervon Biopharmaceuticals poised to find Big Pharma partner to commercialize its GM6 drug

Genervon Biopharmaceuticals CEO Winston Ko tells Proactive Investors he's fresh off of a speaking engagement at the American Society of Experimental Neurotherapeutics, where he explained how Genervo...

GDCC Acquires China Rights to Anti-Seizure Drug from Biscayne Neuro

Global Drug Development Centre China (GDCC) acquired greater China rights to a clinical stage anti-seizure product from Biscayne Neurotherapeutics of Miami. Biscayne described the candidate, BIS-001ER...

Neurostimulation device maker Nuvectra closes $21mm FOPO

Through a follow-on public offering of 2.8mm shares priced at $8, neurostimulation device developer Nuvectra Corp. netted $21mm. A public company since its 2016 spin-off from Greatbatch, Nuvectra has ...

Neurostimulation device maker Nuvectra closes $24mm FOPO

Through a follow-on public offering of 3.2mm shares, including the overallotment, priced at $8, neurostimulation device developer Nuvectra Corp. netted $24mm. A public company since its 2016 spin-off ...

Drugs and Medications [0 Results]

None

PubMed Articles [24 Associated PubMed Articles listed on BioPortfolio]

Neurotherapeutics: Recent Developments.

[Full article available at http://rimed.org/rimedicaljournal-2018-03.asp].

Do pre-clinical multiple sclerosis models allow us to measure neurodegeneration and clinical progression?

To diagnose or not to diagnose? Timing is the question: balancing early diagnosis of multiple sclerosis with misdiagnosis.

Nerve Ultrasound Predicts Treatment Response in Chronic Inflammatory Demyelinating Polyradiculoneuropathy-a Prospective Follow-Up.

As reliable biomarkers of disease activity are lacking, monitoring of therapeutic response in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) remains a challenge. We sought to determi...

Clinical Trials in Traumatic Spinal Cord Injury.

Traumatic spinal cord injury (SCI) results in impaired neurologic function that for many individuals is permanent and significantly impacts health, function, quality of life, and life expectancy. Many...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Cognitive Training for PTSD

Posttraumatic stress disorder (PTSD) is a chronic, disabling condition that occurs in a subgroup of individuals after experiencing traumatic stress, and is common in Veterans seeking menta...

Companies [5 Associated Companies listed on BioPortfolio]

Embera NeuroTherapeutics Inc.

Embera NeuroTherapeutics, Inc. is a development-stage pharmaceutical company focused on treating a broad range of addictions where the major clinical challenge is a limited range ...

Embera NeuroTherapeutics, Inc.

Embera NeuroTherapeutics, Inc. is a development stage pharmaceutical company focused on treating a broad range of addictions and obesity where the major clinical challenge is a li...

NeuroTherapeutics Pharma, Inc.

NeuroTherapeutics Pharma is a privately held life sciences company which is focused on the discovery and development of novel therapeutics for patients suffering from CNS disorder...

Tetra Discovery Partners Inc.

Tetra Discovery Partners is a clinical stage biotechnology company developing a portfolio of therapeutic products that will bring clarity of thought to people suffering from Alzhe...

Proneuron Biotechnologies (Israel) Limited

Proneuron Biotechnologies is developing therapies for neurological, ophthalmologic and immune-related disorders such as spinal cord injuries, multiple sclerosis, glaucoma, Parkinson's disease and Alzh...

More Information about "Embera NeuroTherapeutics, Inc." on BioPortfolio

We have published hundreds of Embera NeuroTherapeutics, Inc. news stories on BioPortfolio along with dozens of Embera NeuroTherapeutics, Inc. Clinical Trials and PubMed Articles about Embera NeuroTherapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Embera NeuroTherapeutics, Inc. Companies in our database. You can also find out about relevant Embera NeuroTherapeutics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Obesity
Obesity is the condition in which excess fat has accumulated in the body (mostly in subcutaneous tissues). clinical obesity is considered to be present when a person has a BMI of over 30 (Oxford Dictionary of Medicine). It is becoming increasing common i...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record